Skip to content
OXGENE - TESSA Infographic

OXGENE - TESSA Infographic

The challenge of scalable AAV manufacture for
gene therapies, and how to overcome it.

Gene therapies offer enormous promise for the treatment of genetic disease. There
are over 1,000 cell and gene therapy clinical trials underway worldwide, indicating
the great potential of this new class of medicines. However, large-scale
manufacture of the viral vectors required to deliver therapeutic genes into patients
still represents a stumbling block in the path to market for gene therapies

Download our free infographic to find out more about the top solutions for large scale AAV production.

To find out more about our TESSA technology, click here.

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.


Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of quality control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.